Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€346.26
Performance (%)
11.07%
Price
09.03.26
€324.45
Summary
This prediction is currently active. The prediction currently has a performance of 11.07%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 15.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.652% | -1.652% |
| iShares Core DAX® | -3,52 % | -4,99 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % |
| iShares S&P 500 | -0,82 % | -0,04 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $400.00 to $403.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat